Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
The Lancet. Neurology|February 5, 2013
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trialRichard Dodel, Axel Rominger, Peter Bartenstein, et al.
Clinical and Translational Allergy|November 18, 2025
Sebetralstat for On-Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT-SJonathan A Bernstein, Emel Aygören-Pürsün, Mauro Cancian, et al.
The New England Journal of Medicine|May 31, 2024
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema AttacksMarc A Riedl, Henriette Farkas, Emel Aygören-Pürsün, et al.
The Journal of Allergy and Clinical Immunology. Global|July 12, 2026
Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-STamar Kinaciyan, Emel Aygören-Pürsün, Inmaculada Martinez-Saguer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 31, 2025
Long-term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label ExtensionHenriette Farkas, John Anderson, Laurence Bouillet, et al.
The World Allergy Organization Journal|June 19, 2026
Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trialsEmel Aygören-Pürsün, Danny M Cohn, Nancy Agmon-Levin, et al.
Pageof 4